Revisiting T-Cell Adhesion Molecules as Potential Targets for Cancer Immunotherapy: CD226 and CD2

The authors explore the current understanding of the functions of CD2 and CD226, placing a special emphasis on their potential as novel agonist targets for cancer immunotherapy.